Delivery Order SPE2DB20D1110-SPE2DB25FK27E
- Not listed
- The Defense Logistics Agency awarded a $4,241.13 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml units). This is a firm fixed-price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion on April 25, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,405.78 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on June 18, 2025, with a completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,855.93 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This firm fixed price delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitively awarded transaction without set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors valued at $10,552.44 under a firm fixed-price contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.57 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $13,780.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on July 21, 2025, with completion targeted for July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,473.52 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on September 12, 2025, with completion targeted for September 15, 2025. This is a firm fixed-price, non-set-aside contract awarded through open competition, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under a larger indefinite delivery vehicle that enables DLA to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $1,632.54 with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK27EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The Mounjaro delivery represents a critical pharmaceutical supply for the Defense Health Agency and military healthcare systems. AmerisourceBergen's DLA contract portfolio demonstrates the company's capability to supply a broad range of pharmaceutical products, from specialty medications and brand-name drugs to generic alternatives and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen has consistently fulfilled competitively awarded contracts with DLA, supporting military personnel, veterans, and other government healthcare beneficiaries with reliable access to essential medications and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/17/25 |